The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SK Hynix's memory business in China faces numerous uncertainties due to the ongoing US-China conflict. Chief Production ...

Elsewhere, WuXi Biologics rallied 3.4 per cent to HK$11.68 and its affiliate Wuxi AppTec appreciated 5.7 per cent to HK$36.35, recovering from a sell-off induced by a US move to ban their ...

The Tech Index fell 1.8 per cent, while the Shanghai Composite Index lost 0.7 per cent. WuXi AppTech tumbled 7.5 per cent to HK$39.55, the lowest level in over a month, after the company gave ...

WuXi AppTec’s leadership played down concerns about reduced demand for glucagon-like peptide-1 receptor agonist (GLP-1RA) manufacturing after leading obesity player Eli Lilly released lower-than ...

Hong Kong IPO: WuXi Biologics unit eyes up to US$520 million in biotech push WuXi XDC, a 60 per cent-owned unit of WuXi Biologics, could raise as much as US$520 million, including excess share ...

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. The deal includes facilities in ...

Upgrade to begin using 40 years of financial statements and get so much more. Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...